Swainsonine hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSwainsonine hydrochloride
Drug Alias Name苦马豆素盐酸盐GD-0039
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-mannosidase 2A1 inhibitors
TargetsAlpha-mannosidase 2A1
Therapy Area/IndicationsHead and Neck NeoplasmsColorectal NeoplasmsCarcinoma, Renal Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrexo Ab (Pulb)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrexo Ab (Pulb)
Active IndicationsN/A
Inactive IndicationsHead and Neck NeoplasmsColorectal NeoplasmsCarcinoma, Renal Cell +[4] 

Other Information

ATC CodeN/A
Related LinksN/A